Abstract
Oestrogen (ER) and progestin receptors (PR) were measured in cytosols from histologically normal mammary tissues (n = 30), and in benign (n = 59) and malignant mammary lesions (n = 49) from female dogs. Receptor levels greater than or equal to 5 fmol mg-1 protein were considered positive. The presence of histologically normal mammary epithelium within specimens of primary tumours was noticed as a factor that may cause false-positive receptor results. Receptor levels in non-malignant tissues, and the receptor status of primary cancers did not vary significantly with regard to the phase of oestrous cycle (anoestrus/metoestrus) or the influence of exogenous progestins. ER- or PR-positivity was more frequent and levels of both receptors were higher in 'normal' tissues and in benign lesions than in primary cancers (P less than 0.001). ER and PR levels were higher in benign lesions of dogs also developing malignant mammary tumours than in benign lesions of dogs that did not (P less than 0.02 and P less than 0.05, respectively). Regional and distant cancer metastases were frequently receptor-negative. In some dogs heterogeneity of receptor status was found between different sites of the same cancer. These findings indicate that in non-malignant mammary tissues of adult female dogs expression of the genes encoding ER and PR is common. In malignant tumours this property may become lost, in particular in advanced states of disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rutteman, G., Misdorp, W., Blankenstein, M. et al. Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states. Br J Cancer 58, 594–599 (1988). https://doi.org/10.1038/bjc.1988.266
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.266
This article is cited by
-
Estrogen receptors alpha and beta expression in different canine cancer types with an emphasis on hematopoietic malignancies
Veterinary Research Communications (2024)
-
Upregulation of SLUG expression in canine mammary gland tumors and its prognostic significance
BMC Veterinary Research (2023)
-
Estrogen receptors genotypes and canine mammary neoplasia
BMC Veterinary Research (2019)
-
Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors
BMC Veterinary Research (2015)
-
The number of ERα and PR in the mammary glands of bitches with and without tumor mass using immunohistochemical assay
Comparative Clinical Pathology (2009)